Literature DB >> 15592481

Failure of fat cell proliferation, mitochondrial function and fat oxidation results in ectopic fat storage, insulin resistance and type II diabetes mellitus.

L Heilbronn1, S R Smith, E Ravussin.   

Abstract

BACKGROUND: It is widely accepted that increasing adiposity is associated with insulin resistance and increased risk of type II diabetes. The predominant paradigm used to explain this link is the portal/visceral hypothesis. This hypothesis proposes that increased adiposity, particularly in the visceral depots, leads to increased free-fatty acid flux and inhibition of insulin-action via Randle's effect in insulin-sensitive tissues.
OBJECTIVES: In this review, limitations of this paradigm will be discussed and two other paradigms that may explain established links between adiposity and insulin resistance/diabetes will be presented. (A) Ectopic fat storage syndrome. Three lines of evidence support this concept. Firstly, failure to develop adequate adipose tissue mass (also known as 'lipodystrophy') results in severe insulin resistance and diabetes. This is thought to be the result of ectopic storage of lipid into liver, skeletal muscle and the pancreatic insulin-secreting beta cell. Secondly, most obese patients also shunt lipid into the skeletal muscle, the liver and probably the beta cell. The importance of this finding is exemplified by several studies demonstrating that the degree of lipid infiltration into skeletal muscle and liver highly correlates with insulin resistance. Thirdly, increased fat cell size is highly associated with insulin resistance and the development of diabetes. Increased fat cell size may represent the failure of the adipose tissue mass to expand and therefore to accommodate an increased energy influx. Taken together, these observations support the 'acquired lipodystrophy' hypothesis as a link between adiposity and insulin resistance. Ectopic fat deposition is therefore the result of additive or synergistic effects including increased dietary intake, decreased fat oxidation and impaired adipogenesis. (B) Endocrine paradigm. This concept was developed in parallel with the 'ectopic fat storage syndrome' hypothesis. Adipose tissue secretes a variety of endocrine hormones such as leptin, interleukin-6, angiotensin II, adiponectin and resistin. From this viewpoint, adipose tissue plays a critical role as an endocrine gland, secreting numerous factors with potent effects on the metabolism of distant tissues.
CONCLUSIONS: The novel paradigms of ectopic fat and fat cell as an endocrine organ probably will constitute a new framework for the study of the links between our obesigenic environment and the risk of developing diabetes.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15592481     DOI: 10.1038/sj.ijo.0802853

Source DB:  PubMed          Journal:  Int J Obes Relat Metab Disord


  132 in total

Review 1.  Adipokines as novel biomarkers and regulators of the metabolic syndrome.

Authors:  Yingfeng Deng; Philipp E Scherer
Journal:  Ann N Y Acad Sci       Date:  2010-11       Impact factor: 5.691

Review 2.  Is all fat the same? The role of fat in the pathogenesis of the metabolic syndrome and type 2 diabetes mellitus.

Authors:  Erik Hansen; Tahar Hajri; Naji N Abumrad
Journal:  Surgery       Date:  2006-06       Impact factor: 3.982

3.  Metabolic and neurologic consequences of chronic lopinavir/ritonavir administration to C57BL/6 mice.

Authors:  Paul J Pistell; Sunita Gupta; Alecia G Knight; Michelle Domingue; Romina M Uranga; Donald K Ingram; Indu Kheterpal; Carmen Ruiz; Jeffrey N Keller; Annadora J Bruce-Keller
Journal:  Antiviral Res       Date:  2010-10-21       Impact factor: 5.970

4.  Congenital and environmental factors associated with adipocyte dysregulation as defects of insulin resistance.

Authors:  Chao-Ping Wang; Fu-Mei Chung; Shyi-Jang Shin; Yau-Jiunn Lee
Journal:  Rev Diabet Stud       Date:  2007-08-10

5.  A new predictor for type 2 diabetes?

Authors:  Alexander Sorisky
Journal:  CMAJ       Date:  2008-01-29       Impact factor: 8.262

6.  Aberrant fatty acid metabolism in skeletal muscle contributes to insulin resistance in zinc transporter 7 (znt7)-knockout mice.

Authors:  Liping Huang; Surapun Tepaamorndech; Catherine P Kirschke; John W Newman; William R Keyes; Theresa L Pedersen; Jureeporn Dumnil
Journal:  J Biol Chem       Date:  2018-03-19       Impact factor: 5.157

7.  Targeting nuclear receptor NR4A1-dependent adipocyte progenitor quiescence promotes metabolic adaptation to obesity.

Authors:  Yang Zhang; Alexander J Federation; Soomin Kim; John P O'Keefe; Mingyue Lun; Dongxi Xiang; Jonathan D Brown; Matthew L Steinhauser
Journal:  J Clin Invest       Date:  2018-10-02       Impact factor: 14.808

8.  Undernutrition and stage of gestation influence fetal adipose tissue gene expression.

Authors:  Jacqueline M Wallace; John S Milne; Raymond P Aitken; Dale A Redmer; Lawrence P Reynolds; Justin S Luther; Graham W Horgan; Clare L Adam
Journal:  J Mol Endocrinol       Date:  2015-04-27       Impact factor: 5.098

9.  Inflammation and adipose tissue macrophages in lipodystrophic mice.

Authors:  Laura Herrero; Hagit Shapiro; Ali Nayer; Jongsoon Lee; Steven E Shoelson
Journal:  Proc Natl Acad Sci U S A       Date:  2009-12-10       Impact factor: 11.205

Review 10.  Mechanisms and metabolic implications of regional differences among fat depots.

Authors:  Tamara Tchkonia; Thomas Thomou; Yi Zhu; Iordanes Karagiannides; Charalabos Pothoulakis; Michael D Jensen; James L Kirkland
Journal:  Cell Metab       Date:  2013-04-11       Impact factor: 27.287

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.